Sensus Healthcare Q3 revenue falls on product mix shift, misses estimates
SRTS•Sensus Healthcare’s third-quarter revenue fell 13% year over year to $6 million, below the $6.61 million consensus estimate. Its net loss widened to $1.49 million from $0.9 million a year earlier, while gross profit and margin improved.
1. Revenue and losses
Sensus Healthcare reported third-quarter revenue of $6 million, down 13% year over year and below analysts’ $6.61 million estimate. Net loss widened to $1.49 million from $0.9 million a year earlier; adjusted EBITDA was a loss of $1.47 million.
2. Product mix and customers
The revenue decline was mainly due to a higher proportion of lower-priced SRT-100 systems and no sales to a historically large customer. Gross profit and margin improved as shipments included a higher proportion of higher-margin SRT-100 units. Two large private equity-backed dermatology groups made initial system purchases, supporting the company’s customer diversification strategy.
3. Outlook
The company did not provide specific financial guidance for future quarters or the full year.
